1. Catalogs
  2. BioStatus
  3. HypoxiTRAK™ TECHNICAL DATA SHEET

HypoxiTRAK™ TECHNICAL DATA SHEET
1 /2Pages

HypoxiTRAK™ TECHNICAL DATA SHEET

HypoxiTRAK™ TECHNICAL DATA SHEET
1 /2Pages

Catalog excerpts

HypoxiTRAK™ TECHNICAL DATA SHEET-1

HypoxiTRAK™ TECHNICAL DATA SHEET PRODUCT: HypoxiTRAK™ PRODUCT NUMBERS: HT10500 PRESENTATION: aqueous solution. STORAGE: store at 2-8 ºC. Do not freeze. DESCRIPTION: HypoxiTRAK™ is a novel, far-red fluorescing dye that reveals hypoxic experience of individual cells yet is non-toxic to normoxic cells. HypoxiTRAK™ suits flow cytometry and imaging protocols and compatible with common vis. range fluors e.g. FITC, R-PE. HypoxiTRAK™ enables entirely new assay approaches to functional hypoxia. APPLICATIONS: Reporting hypoxia experience in cell cultures, spheroids and tissues: • Flow Cytometry – dynamic live cell hypoxia study • Fluorescence Microscopy – dynamic live cell hypoxia study; immuno-fluorescence BACKGROUND INFORMATION: Hypoxia’s role in cancer and stem cells is an expanding research area. Low oxygen stress can alter biological behaviour and pharmaco-dynamic responses via hypoxiainduced activation of cell-protective and proliferation mechanisms. HypoxiTRAK™ is a novel molecular probe for use in flow cytometry and imaging to report (i) degree of hypoxic experience of cells and (ii) functionally hypoxic fraction of cells. HypoxiTRAK™ is designed to activate by bio-reduction at biologically relevant levels of hypoxia, since in vivo tumour cells can occupy hypoxic niches with lower median oxygen levels (~1 % oxygen; pO 2 7.5 mmHg) compared to normal tissues (~5.5% oxygen; pO2 42 mmHg) while tumour cores may maintain a less than 0.1% oxygen (pO2 1 mm Hg) environment. Hypoxia sensing range for HypoxiTRAK™ is relevant to biomarker and hypoxia-targeting drug development. The bioactive metabolite retains the parent fluorophore and accumulates in cells, proportional to the hypoxia experienced, to provide a persistent far-red fluorescent signature and induces cell arrest, thereby marking and ‘freezing’ the hypoxic cells, enabling a direct read-out of a hypoxic cell fraction. SPECTRAL CHARACTERISTICS: Exλmax 600/646 nm Emλmax 697 nm Flow cytometric detection of far-red fluorescent HypoxiTRAK-metabolite in intact human lung cancer A549 cells under different levels of hypoxia [4 day co-exposure] Fig. 1 Flow cytometry of HypoxiTRAK™-metabolite, blue & red excitation; intact A549 cells under hypoxia (3%, 1%), with & without HypoxiTRAK™ [4 day co-exposure] Fig. 2 HypoxiTRAK™-metabolite accumulates in cytoplasm of A549 cells (ex. 633 nm; em. 680/20 nm) exposed to 100 nM HypoxiTRAK™ for 4 days 1% O 2 HypoxiTRAK™ allows assessment of degree of hypoxia by simple assays for growth arrest or apoptosis. HypoxiTRAK™ bio-activation, resulting in prolonged cell cycle arrest, can be detected by increased side scatter by flow cytometry. As no fixation is required, HypoxiTRAK™ provides a convenient negative selection for cells not experiencing relevant hypoxia within a heterogeneous population, including 3D culture. HypoxiTRAK™ shares spectral features with the DNA dye DRAQ5™, that labels all nucleated cells, a convenient standard to mark all cells within a sample in parallel with analysis for hypoxic fraction. HypoxiTRAK™ is typically present during the period of hypoxia under investigation. The physicochemical properties of HypoxiTRAK™ facilitate permeation throughout populations of cells in 2D and 3-D culture (2) and tissues thereby enhancing its entry into hypoxic niches and reducing retention upon cell isolation, providing a good signal:noise. HypoxiTRAK™ is ideal for studies over several days. HypoxiTRAK™ readout is direct, obviating cell processing. HypoxiTRAK™ shows low perturbation in the absence of bio-activation while the unique far-red fluorescence signature offers compatibility with other fluorescent end-point assays for hypoxia. Fig.3 Intracellular accumulation of HypoxiTRAK™metabolite is sensitive to degree of hypoxia and [HypoxiTRAK] (A549 cells, conditions as fig. 2) Oxygen levels vary in extent and duration; HypoxiTRAK™ provides a retrospective / historical reporting of the integrated hypoxic experience of a cell – it is a reporter of the hypoxia experienced by each cell within an in vitro cell population. BEFORE STARTING: Read the MSDS. Wear protective clothing, safety goggles and laboratory gloves. Check the concentration of HypoxiTRAK™ stated on the vial label. MATERIALS OFTEN REQUIRED BUT NOT SUPPLIED: PBS (azide-free), culture medium (CM), CM without phenol-red (“Imaging CM”), Paraformaldehyde, Antibodies. Document Ref: HT1.TDS Version #: 005 Issue date: 16/05/23 Fig. 4 HypoxiTRAK™-metabolite persistence: intact A549 cells retain >70% after washing and 24h incubation in HypoxiTRAK™-free medium (ex. 633nm; em

 Open the catalog to page 1
HypoxiTRAK™ TECHNICAL DATA SHEET-2

FOR FURTHER INFORMATION PLEASE CONTACT: BioStatus Limited Website: www.biostatus.com Technical Support: [email protected] Re-ordering: [email protected] BioStatus Limited 56A Charnwood Road, Shepshed, Leicestershire LE12 9NP UK Company registered in England and Wales. No. 3079239 HypoxiTRAK™ TECHNICAL DATA SHEET **NOTE: retained HypoxiTRAK™-metabolite inhibits cell division - marking and preserving cells that have experienced hypoxic conditions. DETECTING HypoxiTRAK™ SIGNALS: (see Fig. 1) Flow cytometry: HypoxiTRAK™-metabolite can be excited by 488 or 635 nm wavelength light. Detect in...

 Open the catalog to page 2
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.